| 2025-09-15 |
详情>>
股本变动：
变动后总股本17099.73万股
|
| 2025-09-15 |
详情>>
业绩披露：
2025年年报每股收益-0.13美元,归母净利润-1.63亿美元,同比去年增长26.09%
|
| 2025-03-17 |
复牌提示：
2025-03-17 10:07:12 停牌，复牌日期 2025-11-20 00:00:01
|
| 2025-02-28 |
详情>>
业绩披露：
2025年中报每股收益-0.11美元,归母净利润-1.32亿美元,同比去年增长-37.15%
|
| 2024-10-16 |
股东大会：
将于2024-11-15召开股东大会
会议内容 ▼▲
- 1.Financial statements and reports.
2.Other business.
|
| 2024-10-16 |
股东大会：
将于2024-11-15召开股东大会
会议内容 ▼▲
- 1.Financial statements and reports.
2.Other business.
|
| 2024-09-20 |
详情>>
业绩披露：
2024年年报每股收益-0.35美元,归母净利润-2.2亿美元,同比去年增长-54.53%
|
| 2024-02-29 |
详情>>
业绩披露：
2024年中报每股收益-0.16美元,归母净利润-9618.54万美元,同比去年增长-24.76%
|
| 2023-09-28 |
详情>>
业绩披露：
2023年年报每股收益-0.32美元,归母净利润-1.43亿美元,同比去年增长-53.55%
|
| 2023-02-23 |
详情>>
业绩披露：
2023年中报每股收益-0.17美元,归母净利润-7709.9万美元,同比去年增长-104.44%
|
| 2022-09-29 |
详情>>
业绩披露：
2020年年报每股收益-0.04美元,归母净利润-1112.32万美元,同比去年增长25.61%
|
| 2022-09-29 |
详情>>
业绩披露：
2022年年报每股收益-0.26美元,归母净利润-9281.74万美元,同比去年增长-104.69%
|
| 2022-08-26 |
股东大会：
将于2022-09-26召开股东大会
会议内容 ▼▲
- 1.Ratification of Tranche 1 Shares Placement
2.Issue of Tranche 2 Shares
|
| 2022-03-30 |
详情>>
业绩披露：
2022年中报每股收益-0.11美元,归母净利润-3771.28万美元,同比去年增长-7.81%
|
| 2021-10-28 |
详情>>
业绩披露：
2021年年报每股收益-0.14美元,归母净利润-4534.45万美元,同比去年增长-307.66%
|
| 2021-09-20 |
股东大会：
将于2021-10-19召开股东大会
会议内容 ▼▲
- 1.To consider and, if thought fit, to pass the following resolution as an ordinary resolution: That Jeremy Levin, appointed by the Board as a director of Opthea on October 5, 2020, and who will retire at the meeting in accordance with clause 57.2 of Opthea’s constitution, and being eligible, be elected as a director of Opthea.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-12-17 |
股东大会：
将于2021-01-19召开股东大会
会议内容 ▼▲
- 1.Issue of options to Jeremy Levin under the non-executive director share and option plan. To consider and, if thought fit, to pass the following resolution as an ordinary resolution: That approval is given for all purposes, including for the purpose of ASX Listing Rule 10.14 and sections 200B and 200E of the Corporations Act, to the issue of 3,000,000 options to Jeremy Levin, to acquire by way of issue upon exercise of the options, a like number of fully paid ordinary shares in the Company, pursuant to the Company’s NED Plan, on the terms set out in the explanatory notes which accompany this Notice.
|